These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36075566)

  • 1. Transcriptome profiling highlights regulated biological processes and type III interferon antiviral responses upon Crimean-Congo hemorrhagic fever virus infection.
    Mo Q; Feng K; Dai S; Wu Q; Zhang Z; Ali A; Deng F; Wang H; Ning YJ
    Virol Sin; 2023 Feb; 38(1):34-46. PubMed ID: 36075566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
    Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjärvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
    Elife; 2022 Apr; 11():. PubMed ID: 35437144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
    Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
    J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection.
    Fraisier C; Rodrigues R; Vu Hai V; Belghazi M; Bourdon S; Paranhos-Baccala G; Camoin L; Almeras L; Peyrefitte CN
    Virus Res; 2014 Jan; 179():187-203. PubMed ID: 24184319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
    Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
    J Virol; 2017 May; 91(10):. PubMed ID: 28250124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-Derived DNA Forms Mediate the Persistent Infection of Tick Cells by Hazara Virus and Crimean-Congo Hemorrhagic Fever Virus.
    Salvati MV; Salaris C; Monteil V; Del Vecchio C; Palù G; Parolin C; Calistri A; Bell-Sakyi L; Mirazimi A; Salata C
    J Virol; 2021 Nov; 95(24):e0163821. PubMed ID: 34613808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle.
    Surtees R; Dowall SD; Shaw A; Armstrong S; Hewson R; Carroll MW; Mankouri J; Edwards TA; Hiscox JA; Barr JN
    J Virol; 2016 Oct; 90(20):9305-16. PubMed ID: 27512070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic antiviral activity between IFN-lambda and IFN-alpha against lethal Crimean-Congo hemorrhagic fever virus in vitro.
    Bordi L; Lalle E; Caglioti C; Travaglini D; Lapa D; Marsella P; Quartu S; Kis Z; Arien KK; Huemer HP; Meschi S; Ippolito G; Di Caro A; Capobianchi MR; Castilletti C
    PLoS One; 2015; 10(2):e0116816. PubMed ID: 25693189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crimean-Congo Hemorrhagic Fever Virus: Current Advances and Future Prospects of Antiviral Strategies.
    Dai S; Deng F; Wang H; Ning Y
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crimean-Congo hemorrhagic fever virus replication imposes hyper-lipidation of MAP1LC3 in epithelial cells.
    Moroso M; Verlhac P; Ferraris O; Rozières A; Carbonnelle C; Mély S; Endtz HP; Peyrefitte CN; Paranhos-Baccalà G; Viret C; Faure M
    Autophagy; 2020 Oct; 16(10):1858-1870. PubMed ID: 31905032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
    Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
    J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a real-time RT-qPCR for detection of Crimean-Congo hemorrhagic fever virus representing different genotypes.
    Jääskeläinen AJ; Kallio-Kokko H; Ozkul A; Bodur H; Korukruoglu G; Mousavi M; Pranav P; Vaheri A; Mirazimi A; Vapalahti O
    Vector Borne Zoonotic Dis; 2014 Dec; 14(12):870-2. PubMed ID: 25514124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.
    Scholte FEM; Hua BL; Spengler JR; Dzimianski JV; Coleman-McCray JD; Welch SR; McMullan LK; Nichol ST; Pegan SD; Spiropoulou CF; Bergeron É
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
    Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus.
    Kozak RA; Fraser RS; Biondi MJ; Majer A; Medina SJ; Griffin BD; Kobasa D; Stapleton PJ; Urfano C; Babuadze G; Antonation K; Fernando L; Booth S; Lillie BN; Kobinger GP
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008105. PubMed ID: 32251473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Growth Characteristics of Crimean-Congo Hemorrhagic Fever Virus in Kidney Cells of Human and Bovine Origin.
    Földes K; Aligholipour Farzani T; Ergünay K; Ozkul A
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32630501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins.
    Dai S; Min YQ; Li Q; Feng K; Jiang Z; Wang Z; Zhang C; Ren F; Fang Y; Zhang J; Zhu Q; Wang M; Wang H; Deng F; Ning YJ
    Nat Commun; 2023 Nov; 14(1):7365. PubMed ID: 37963884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus.
    Mears MC; Rodriguez SE; Schmitz KS; Padilla A; Biswas S; Cajimat MNB; Mire CE; Welch SR; Bergeron É; Alabi CA; Porotto M; Bente DA
    Antiviral Res; 2022 Nov; 207():105401. PubMed ID: 36049554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.